Skip to main content
. 2015 Jan 21;4(1):e001486. doi: 10.1161/JAHA.114.001486

Table 3.

Distribution of CHADS2 and CHA2DS2_VASC Scores Risk Categories and Rate of Persistent Treatment With Warfarin

Low Risk (Score 0) Intermediate Risk (Score 1) High Risk (Score ≥2)
CHADS2 12 296 (12.4%) 22 806 (23.1%) 63 709 (64.5%)
Warfarin treatment, n (%) 1659 (13.5%) 6107 (26.8%) 17 662 (27.7%)
CHA2DS2_VASC 4300 (4.4%) 8868 (9.0%) 85 643 (86.7%)
Warfarin treatment, n (%) 452 (10.5%) 1459 (16.5%) 23 517 (27.5%)